AQR CAPITAL MANAGEMENT LLC recently filed their 13F report for the first quarter of 2022, which ended on 2022-03-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
AQR Capital Management LLC is an investment management firm that was founded in 1998 by Clifford S. Asness, David G. Kabiller, Robert J. Krail; and John M. Liew. The company’s first product was a hedge fund, but there was intention from the start to expand. AQR Capital Management would expand into traditional portfolio management in 2000 and then form a partnership with CNH in 2004 to add convertible arbitrage and merger strategies into its line of offerings, becoming one of the first investment managers to have alternative strategies offered in a mutual fund format in 2009. The company’s philosophy is to focus on delivering “superior, long-term results for our clients by seeking to filter out market noise to identify and isolate what matters most, and by developing ideas that stand up to rigorous testing.” AQR Capital Management utilizes a research driven approach to conduct its business, focusing on quantitative analysis to provide fundamental investment information and risks. Research is very important to the founders and company values and the company has endowed the AQR Capital Management Distinguished Service Professor of Finance chair at the University of Chicago: Booth School of Business and regularly publishes articles in leading financial journals that have won various awards and recognitions. Its line of products and services are offered to its broad client base including pension funds, insurance companies, endowments, foundations, sovereign wealth funds, and financial advisors. The company currently has over 500 employees and 24 principals with over a third of the employees holding advanced degrees. AQR Capital Management is currently based in Greenwich and has additional offices in Chicago, Los Angeles, London, and Sydney. As of 2015, the company has a total asset under management value of approximately $132 billion. Some of the company’s mutual funds include its Equity Market Neutral Fund, Risk-Balanced Commodities Strategy Fund, Risk Parity Fund, Large Cap Defensive Style Fund, and Large Cap Momentum Style Fund.
As of the latest 13F report, the guru’s equity portfolio contained 2210 stocks valued at a total of $52,674,000,000. The top holdings were AAPL(3.48%), MSFT(3.19%), and GOOGL(1.65%).
According to GuruFocus data, these were AQR CAPITAL MANAGEMENT LLC’s top five trades of the quarter.
Meta Platforms Inc
During the quarter, AQR CAPITAL MANAGEMENT LLC bought 948,289 shares of NAS:FB for a total holding of 2,959,652. The trade had a 0.4% impact on the equity portfolio. During the quarter, the stock traded for an average price of $250.52.
On 05/18/2022, Meta Platforms Inc traded for a price of $193.7263 per share and a market cap of $524,187,778,000. The stock has returned -35.77% over the past year.
GuruFocus gives the company a financial strength rating of 8 out of 10 and a profitability rating of 10 out of 10.
In terms of valuation, Meta Platforms Inc has a price-earnings ratio of 14.93, a price-book ratio of 4.34, a price-earnings-to-growth (PEG) ratio of 0.56, a EV-to-Ebitda ratio of 9.70 and a price-sales ratio of 4.64.
The price-to-GF Value ratio is 0.49, earning the stock a GF Value rank of 4.
Pfizer Inc
During the quarter, AQR CAPITAL MANAGEMENT LLC bought 3,857,765 shares of NYSE:PFE for a total holding of 10,703,494. The trade had a 0.38% impact on the equity portfolio. During the quarter, the stock traded for an average price of $51.88.
On 05/18/2022, Pfizer Inc traded for a price of $50.39 per share and a market cap of $282,200,006,000. The stock has returned 31.94% over the past year.
GuruFocus gives the company a financial strength rating of 7 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Pfizer Inc has a price-earnings ratio of 11.54, a price-book ratio of 3.42, a price-earnings-to-growth (PEG) ratio of 1.10, a EV-to-Ebitda ratio of 8.60 and a price-sales ratio of 3.13.
The price-to-GF Value ratio is 0.62, earning the stock a GF Value rank of 8.
Moderna Inc
During the quarter, AQR CAPITAL MANAGEMENT LLC bought 847,320 shares of NAS:MRNA for a total holding of 1,365,370. The trade had a 0.28% impact on the equity portfolio. During the quarter, the stock traded for an average price of $168.57.
On 05/18/2022, Moderna Inc traded for a price of $137.98 per share and a market cap of $54,628,290,000. The stock has returned -15.57% over the past year.
GuruFocus gives the company a financial strength rating of 9 out of 10 and a profitability rating of 4 out of 10.
In terms of valuation, Moderna Inc has a price-earnings ratio of 4.05, a price-book ratio of 3.22, a EV-to-Ebitda ratio of 2.75 and a price-sales ratio of 2.62.
The price-to-GF Value ratio is 0.04, earning the stock a GF Value rank of 2.
Thermo Fisher Scientific Inc
AQR CAPITAL MANAGEMENT LLC reduced their investment in NYSE:TMO by 235,464 shares. The trade had a 0.28% impact on the equity portfolio. During the quarter, the stock traded for an average price of $574.18.
On 05/18/2022, Thermo Fisher Scientific Inc traded for a price of $544.245 per share and a market cap of $212,528,634,000. The stock has returned 22.69% over the past year.
GuruFocus gives the company a financial strength rating of 5 out of 10 and a profitability rating of 9 out of 10.
In terms of valuation, Thermo Fisher Scientific Inc has a price-earnings ratio of 28.31, a price-book ratio of 5.19, a price-earnings-to-growth (PEG) ratio of 1.20, a EV-to-Ebitda ratio of 20.26 and a price-sales ratio of 5.23.
The price-to-GF Value ratio is 0.92, earning the stock a GF Value rank of 7.
Target Corp
AQR CAPITAL MANAGEMENT LLC reduced their investment in NYSE:TGT by 635,936 shares. The trade had a 0.26% impact on the equity portfolio. During the quarter, the stock traded for an average price of $216.25.
On 05/18/2022, Target Corp traded for a price of $160.85 per share and a market cap of $73,942,121,000. The stock has returned 4.54% over the past year.
GuruFocus gives the company a financial strength rating of 6 out of 10 and a profitability rating of 8 out of 10.
In terms of valuation, Target Corp has a price-earnings ratio of 11.33, a price-book ratio of 5.85, a price-earnings-to-growth (PEG) ratio of 0.81, a EV-to-Ebitda ratio of 7.12 and a price-sales ratio of 0.75.
The price-to-GF Value ratio is 0.77, earning the stock a GF Value rank of 5.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
